BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11336617)

  • 1. Clinical review of glimepiride.
    McCall AL
    Expert Opin Pharmacother; 2001 Apr; 2(4):699-713. PubMed ID: 11336617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glimepiride. A review of its use in the management of type 2 diabetes mellitus.
    Langtry HD; Balfour JA
    Drugs; 1998 Apr; 55(4):563-84. PubMed ID: 9561345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride: role of a new sulfonylurea in the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 1998 Oct; 32(10):1044-52. PubMed ID: 9793597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M
    Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE; Matthews DR
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glimepiride (Amaryl): a review of its pharmacological and clinical profile].
    Bando K; Yamada Y
    Nihon Yakurigaku Zasshi; 2001 Jul; 118(1):59-67. PubMed ID: 11496829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfonylurea treatment of type 2 diabetes mellitus: focus on glimepiride.
    Korytkowski MT
    Pharmacotherapy; 2004 May; 24(5):606-20. PubMed ID: 15162895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Glimepiride--an oral antidiabetic agent].
    Becić F; Kapić E; Becić E
    Med Arh; 2003; 57(2):125-7. PubMed ID: 12822388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glimepiride in the treatment of type 2 diabetes mellitus.
    Briscoe VJ; Griffith ML; Davis SN
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):225-35. PubMed ID: 20055691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics.
    Müller G; Hartz D; Pünter J; Okonomopulos R; Kramer W
    Biochim Biophys Acta; 1994 May; 1191(2):267-77. PubMed ID: 8172912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of mortality and cardiovascular event risk associated with various insulin secretagogues: A nationwide real-world analysis.
    Huang HK; Yeh JI
    Diabetes Res Clin Pract; 2019 Jun; 152():103-110. PubMed ID: 31108137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone plus glimepiride: a promising alternative in metabolic control.
    Derosa G
    Int J Clin Pract Suppl; 2007 Jun; (153):28-36. PubMed ID: 17594391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical profile of glimepiride.
    Draeger E
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S139-46. PubMed ID: 8529506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation, efficacy and tolerability of GlucoNovax tablet in type 2 diabetic patients.
    Ali Z; Daniyal M; S I I; Usmanghani K; Naveed S
    Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1443-9. PubMed ID: 27592478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 20. The newly developed sulfonylurea glimepiride: a new ingredient, an old recipe.
    Veneman TF; Tack CJ; van Haeften TW
    Neth J Med; 1998 May; 52(5):179-86. PubMed ID: 9652156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.